Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable…
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared…
uniQure to Announce Third Quarter 2025 Financial Results
LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V.…
INTREPID Alliance Launches Antiviral Toolbox to Support Global Research Community
Open-access resource includes Registry of Antiviral Compound Libraries to help catalyze drug…
Endura Mass Becomes Official Weight Gainer Nutrition Partner for Lucknow Super Giants
Endura Mass the leading weight gain supplement brand from Cipla Health has…
AMSC to Report Second Quarter Fiscal Year 2025 Financial Results on November 5, 2025
October 31, 2025 16:33 ET | Source: AMSC AYER, Mass., Oct. 31,…
Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease
In Canada, lecanemab is indicated for the treatment of adult patients with…
Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Alira Health today released…
MIT Technology Review’s EmTech MIT 2025: Leading with Transformative Technology
MIT's flagship conference returns November 4–6 to explore how to lead with…
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces…